Amazon is now offering GLP-1 weight-loss medications, specifically Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound and Foundayo, to Medicare Part D patients. These drugs will be priced at $50 per month and are available in both oral and injectable forms. The company is providing free home delivery and same-day shipping in over 3,100 U.S. locations, without the need for a Prime membership.

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

https://www.wsj.com/health/pharma/amazon-to-offer-glp-1-weight-loss-drugs-to-medicare-part-d-patients-2b049915

Amazon to Offer GLP-1 Weight-Loss Drugs to Medicare Part D Patients

Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound and Foundayo will be available at a cost of $50 a month

Josée Rose

Listen

(2 min)

A pharmacy manager at a Amazon pharmacy in Corona, Calif. Terry Pierson/Associated Press

Amazon AMZN-0.14%decrease; down pointing triangle.com said patients with Medicare Part D prescription plans now have access to certain GLP-1 weight-loss medications through Amazon Pharmacy.

Oral and injectable versions of Novo Nordisk’s NOVO.B-0.24%decrease; down pointing triangle Wegovy and Eli Lilly’s LLY1.89%increase; up pointing triangle Zepbound KwikPen and Foundayo pills will be available and cost $50 a month with free home delivery, Amazon said. It’s offering same-day delivery in more than 3,100 U.S. locations, and no Prime membership is required, the company added.

Amazon to Offer GLP-1 Weight-Loss Drugs to Medicare Part D Patients

Amazon to Offer GLP-1 Weight-Loss Drugs to Medicare Part D Patients

Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound and Foundayo will be available at a cost of $50 a month

Videos

Most Popular News

Most Popular

Further Reading

The Latest Senior-Citizen Special Is Here: Cheap Weight-Loss Drugs